Virus-derived particles target blood cancer
Ottawa researchers have developed unique virus-derived particles that can kill human blood cancer cells in the laboratory and eradicate the disease in mice with few side effects. The study is published in Blood Cancer Journal ...
Aug 13, 2013
0
0